MOF-based Nanoactivator Enhances Therapy for Primary and Metastatic Triple-Negative Breast Cancer.

https://pubmed.ncbi.nlm.nih.gov/38095158

A MOF-based nanoactivator has been developed to enhance microwave thermo-dynamic-chemotherapy and immunotherapy for efficient inhibition of primary and distal triple-negative breast cancer tumors and metastases.